Klamerus Mandi L, Damschroder Laura J, Sparks Jordan B, Skurla Sarah E, Kerr Eve A, Hofer Timothy P, Caverly Tanner J
Center for Clinical Management Research, Department of Veterans Affairs, Ann Arbor, MI, United States.
Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, United States.
JMIR Res Protoc. 2019 Nov 26;8(11):e15618. doi: 10.2196/15618.
Overtreatment and overtesting expose patients to unnecessary, wasteful, and potentially harmful care. Reducing overtreatment or overtesting that has become ingrained in current clinical practices and is being delivered on a routine basis will require solutions that incorporate a deep understanding of multiple perspectives, particularly those on the front lines of clinical care: patients and their clinicians. Design approaches are a promising and innovative way to incorporate stakeholder needs, desires, and challenges to develop solutions to complex problems.
This study aimed (1) to engage patients in a design process to develop high-level deintensification strategies for primary care (ie, strategies for scaling back or stopping routine medical services that more recent evidence reveals are not beneficial) and (2) to engage both patients and primary care providers in further co-design to develop and refine the broad deintensification strategies identified in phase 1.
We engaged stakeholders in design charrettes-intensive workshops in which key stakeholders are brought together to develop creative solutions to a specific problem-focused on deintensification of routine overuse in primary care. We conducted the study in 2 phases: a 6.5-hour design charrette with 2 different groups of patients (phase 1) and a subsequent 4-hour charrette with clinicians and a subgroup of phase 1 patients (phase 2). Both phases included surveys and educational presentations related to deintensification. Phase 1 involved several design activities (mind mapping, business origami, and empathy mapping) to help patients gain a deeper understanding of the individuals involved in deintensification. Following that, we asked participants to review hypothetical scenarios where patients, clinicians, or the broader health system context posed a barrier to deintensification and then to brainstorm solutions. The deintensification themes identified in phase 1 were used to guide phase 2. This second phase primarily involved 1 design activity (WhoDo). In this activity, patients and clinicians worked together to develop concrete actions that specific stakeholders could take to support deintensification efforts. This activity included identifying barriers to the actions and approaches to overcoming those barriers.
A total of 35 patients participated in phase 1, and 9 patients and 7 clinicians participated in phase 2. The analysis of the deintensification strategies and survey data is currently underway. The results are expected to be submitted for publication in early 2020.
Health care interventions are frequently developed without input from the people who are most affected. The exclusion of these stakeholders in the design process often influences and limits the impact of the intervention. This study employed design charrettes, guided by a flexible user-centered design model, to bring clinicians and patients with differing backgrounds and with different expectations together to cocreate real-world solutions to the complex issue of deintensifying medical services.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR1-10.2196/15618.
过度治疗和过度检查会让患者接受不必要、浪费且可能有害的医疗服务。减少已在当前临床实践中根深蒂固且常规进行的过度治疗或过度检查,需要能深入理解多个视角的解决方案,尤其是临床护理一线人员(患者及其临床医生)的视角。设计方法是一种很有前景且创新的方式,可纳入利益相关者的需求、愿望和挑战,以开发复杂问题的解决方案。
本研究旨在(1)让患者参与设计过程,以制定初级保健的高层次去强化策略(即缩减或停止常规医疗服务的策略,最新证据显示这些服务并无益处),以及(2)让患者和初级保健提供者共同参与进一步的协同设计,以开发和完善在第一阶段确定的广泛去强化策略。
我们让利益相关者参与设计研讨班——一种强化研讨会,将关键利益相关者聚集在一起,针对初级保健中常规过度使用的去强化这一特定问题开发创造性解决方案。我们分两个阶段进行研究:与两组不同的患者进行为期6.5小时的设计研讨班(第一阶段),以及随后与临床医生和第一阶段患者的一个子群体进行为期4小时的研讨班(第二阶段)。两个阶段都包括与去强化相关的调查和教育讲座。第一阶段涉及多项设计活动(思维导图、商业折纸和同理心映射),以帮助患者更深入地了解参与去强化的各方人员。在此之后,我们要求参与者审视假设情景,即患者、临床医生或更广泛的卫生系统背景对去强化构成障碍的情景,然后集思广益提出解决方案。第一阶段确定的去强化主题用于指导第二阶段。第二阶段主要涉及一项设计活动(WhoDo)。在这项活动中,患者和临床医生共同努力制定具体行动,特定利益相关者可采取这些行动来支持去强化工作。这项活动包括识别行动的障碍以及克服这些障碍的方法。
共有35名患者参与了第一阶段,9名患者和7名临床医生参与了第二阶段。目前正在对去强化策略和调查数据进行分析。预计结果将于2020年初提交发表。
医疗保健干预措施的制定常常没有受影响最大的人群的参与。在设计过程中排除这些利益相关者往往会影响并限制干预措施的效果。本研究采用以灵活的用户为中心的设计模型为指导的设计研讨班,将背景不同、期望各异的临床医生和患者聚集在一起,共同为医疗服务去强化这一复杂问题创建现实世界的解决方案。
国际注册报告识别码(IRRID):RR1 - 10.2196/